Supplementary Data 1 from DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer

Read full text Summarise with VIRAT
Authors: Komal L. Jhaveri, Sherene Loi, Erika Paige Hamilton, Peter Schmid, Carey K. Anders, Laura Testa, Hans Wildiers, Ling-Ming Tseng, Yen‐Shen Lu, Yeon Hee Park, Seock‐Ah Im, Shin-Cheh Chen
+6 more Robyn R. Young, Caron Lloyd, Magdalena Wrona, Cuihong Zhang, Danielle K. Carroll, Fabrice André
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies Gastric Cancer Management and Outcomes

Publication details

Publication date
25 March 2026
Language
EN